Bank of Montreal’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Bank of Montreal’s Portfolio STSA Stock Details STSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-256	Closed	-$1K	–	5245
2021 Q1	$1K	Sell	256 -21,165	-99%	-$128K	﹤0.01%	5024
2020 Q4	$105K	Sell	21,421 -14,005	-40%	-$60.4K	﹤0.01%	3559
2020 Q3	$138K	Buy	35,426 +34,687	+4,694%	+$697K	﹤0.01%	2917
2020 Q2	$19K	Buy	+739	New	+$17.1K	﹤0.01%	3881
2020 Q1	–	Sell	-559	Closed	-$11K	–	4892
2019 Q4	$11K	Buy	+559	New	+$7.94K	﹤0.01%	4551

Other funds holding STSA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of Montreal's STSA Position: Q2 2021 in Review

Bank of Montreal sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q2 2021, closing a stake of 256 shares — an estimated $1K sold.

Bank of Montreal first reported a position in STSA in Q4 2019 and held it in 5 quarters. The position peaked at $138K in Q3 2020. 60 funds tracked by Wall St. Rank hold STSA as of Q2 2021.

Bank of Montreal reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Bank of Montreal sold 256 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $1K.
Bank of Montreal first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
Bank of Montreal's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $138K in Q3 2020.
60 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.